Recombinant KRT20 anticorps

N° du produit ABIN7881388

L’anticorps anti-KRT20 Monoclonal Lapin est utilisé pour la détection de KRT20 dans des échantillons de Humain. Il a été validé pour IHC (p).

Aperçu rapide pour Recombinant KRT20 anticorps (ABIN7881388)

Antigène: KRT20 (Keratin 20 (KRT20))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp KRT20 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: KRT20-4380R

Détail du produit anti-KRT20 anticorps

Fonction: Recombinant KRT20 Antibody / Cytokeratin 20 (azide and preservative free)

Purification: Protein A/G affinity

Immunogène: A portion of amino acids 324 424 was used as the immunogen for the recombinant KRT20 antibody.

Isotype: IgG, kappa

Information d'application

Indications d'application: Optimal dilution of the recombinant KRT20 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: -20 °C

Stockage commentaire: Aliquot the recombinant KRT20 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur KRT20

Antigène: KRT20 (Keratin 20 (KRT20))

Autre désignation: KRT20

Sujet: This MAb recognizes an intermediate filament protein of 46 kDa, identified as CK20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.

UniProt: P35900